The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Adenocarcinoma, Papillary

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Adenocarcinoma, Papillary

 

High impact information on Adenocarcinoma, Papillary

  • The tumor showed a feature of well-differentiated, mucin-producing papillary adenocarcinoma in the primary site while, in the metastatic foci, it produced solid cell clusters with a tendency toward the differentiation into squamous cells [5].
  • In all of the papillary adenocarcinoma samples, PA28-gamma was abnormally overexpressed, especially in cancer cells existing at the peripheral region of the cancer mass or in cancer cells invading the capsular region surrounding the cancer mass [6].
  • CONCLUSIONS: In patients with advanced ovarian serous papillary adenocarcinoma, these results suggest that patients with an unfavorable clinical outcome are characterized by increased levels of coordinated MRP1 and MRP3 mRNA expression in their tumor samples [7].
  • These findings strongly suggest that PTH could be produced ectopically by the papillary adenocarcinoma of the thyroid gland [8].
  • In contrast, whereas clone B2F bound equally well to normal Tg and Tg from patients with Graves' disease, adenoma, and follicular carcinoma, this clone bound poorly to Tg from patients with papillary adenocarcinoma [2].
 

Chemical compound and disease context of Adenocarcinoma, Papillary

 

Biological context of Adenocarcinoma, Papillary

 

Anatomical context of Adenocarcinoma, Papillary

 

Gene context of Adenocarcinoma, Papillary

 

Analytical, diagnostic and therapeutic context of Adenocarcinoma, Papillary

References

  1. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Hirotsune, S., Hatada, I., Komatsubara, H., Nagai, H., Kuma, K., Kobayakawa, K., Kawara, T., Nakagawara, A., Fujii, K., Mukai, T. Cancer Res. (1992) [Pubmed]
  2. Monoclonal antibodies to thyroglobulin elucidate differences in protein structure of thyroglobulin in healthy individuals and those with papillary adenocarcinoma. Kohno, Y., Tarutani, O., Sakata, S., Nakajima, H. J. Clin. Endocrinol. Metab. (1985) [Pubmed]
  3. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2. Cathro, H.P., Mills, S.E. Am. J. Surg. Pathol. (2004) [Pubmed]
  4. Genetic alterations in thyroid tumor progression: association with p53 gene mutations. Ito, T., Seyama, T., Mizuno, T., Tsuyama, N., Hayashi, Y., Dohi, K., Nakamura, N., Akiyama, M. Jpn. J. Cancer Res. (1993) [Pubmed]
  5. Biliary cystadenocarcinoma diagnosed by liver biopsy performed under ultrasonographic guidance. Iemoto, Y., Kondo, Y., Nakano, T., Tsuchiya, K., Ohto, M. Gastroenterology (1983) [Pubmed]
  6. Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. Okamura, T., Taniguchi, S., Ohkura, T., Yoshida, A., Shimizu, H., Sakai, M., Maeta, H., Fukui, H., Ueta, Y., Hisatome, I., Shigemasa, C. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  7. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma. Ohishi, Y., Oda, Y., Uchiumi, T., Kobayashi, H., Hirakawa, T., Miyamoto, S., Kinukawa, N., Nakano, H., Kuwano, M., Tsuneyoshi, M. Clin. Cancer Res. (2002) [Pubmed]
  8. Hypercalcemia caused by ectopic production of parathyroid hormone in a patient with papillary adenocarcinoma of the thyroid gland. Iguchi, H., Miyagi, C., Tomita, K., Kawauchi, S., Nozuka, Y., Tsuneyoshi, M., Wakasugi, H. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  9. Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms. Kutteh, W.H., Kutteh, C.C. Am. J. Obstet. Gynecol. (1992) [Pubmed]
  10. Expression patterns of type II pneumocyte apical surface glycoconjugates in lung adenocarcinoma cells. Hachiya, T., Honda, T., Kubo, K., Sekiguchi, M. Virchows Arch. (1999) [Pubmed]
  11. Tumor angiogenesis and thymidine phosphorylase expression in ovarian carcinomas including serous surface papillary adenocarcinoma of the peritoneum. Terai, Y., Ueda, M., Kumagai, K., Ueki, K., Ueki, M. Int. J. Gynecol. Pathol. (2000) [Pubmed]
  12. Effect of synthetic protease inhibitor on histologic changes and free radical activity in hamsters with pancreatic cancer. Manabe, T., Asano, N., Yoshimura, T., Suwa, H., Imamura, T., Ohshio, G. Scand. J. Gastroenterol. (1993) [Pubmed]
  13. Renal papillary adenocarcinoma with unusual metastases: case report and review of the literature. Mearini, L., Zucchi, A., Pizzirusso, G., Costantini, E., Mearini, E. Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia. (2004) [Pubmed]
  14. Establishment of a human chorionic gonadotropin-producing human gastric carcinoma in nude mice. Takahashi, Y., Ueno, M., Mai, M. Journal of surgical oncology. (1991) [Pubmed]
  15. Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture. Emoto, M., Oshima, K., Ishiguro, M., Iwasaki, H., Kawarabayashi, T., Kikuchi, M. Pathol. Res. Pract. (1999) [Pubmed]
  16. Low grade papillary adenocarcinoma of minor salivary gland origin. Diagnosis by fine needle aspiration cytology. Pisharodi, L.R. Acta Cytol. (1997) [Pubmed]
  17. Monoclonal antibody KP16D3 as a prognostic marker in stage I lung adenocarcinoma. Suehiro, T., Ishida, T., Sugio, K., Sugimachi, K., Sueishi, K. Journal of surgical oncology. (1993) [Pubmed]
  18. Case report: multiple cancers: hepatocellular carcinoma and adenocarcinomas of the common bile duct and the gall-bladder in a woman with primary biliary cirrhosis. Imada, J., Hoshino, H., Nishimura, D., Morita, K., Yoshida, N., Katada, N., Sano, H., Kato, K., Mori, N. J. Gastroenterol. Hepatol. (1996) [Pubmed]
  19. Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report. Nagai, N., Hirata, E., Kusuda, T., Mukai, K., Arihiro, K., Ohama, K. Int. J. Gynecol. Cancer (2005) [Pubmed]
  20. Mucin-secreting papillary adenocarcinoma of the hyoid bone: a unique case. Burnell, I., Tomkinson, A., Hourihan, M., Robinson, M., Douglas-Jones, A. The Journal of laryngology and otology. (2005) [Pubmed]
  21. Epidermal growth factor receptor (EGF-R) and transforming growth factor alpha (TGFA) expression in different endometrial cancers. Jasonni, V.M., Amadori, A., Santini, D., Ceccarelli, C., Naldi, S., Flamigni, C. Anticancer Res. (1995) [Pubmed]
  22. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Akyürek, N., Akyol, G., Dursun, A., Yamaç, D., Günel, N. Pathol. Res. Pract. (2002) [Pubmed]
  23. Protease-activating-receptor-2 is frequently expressed in papillary adenocarcinoma of the gallbladder. Shibata, K., Yada, K., Matsumoto, T., Sasaki, A., Ohta, M., Kitano, S. Oncol. Rep. (2004) [Pubmed]
  24. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy. Kawahira, H., Kobayashi, S., Kaneko, K., Asano, T., Ochiai, T. Hepatogastroenterology (2000) [Pubmed]
  25. A clinical and immunohistochemical study of papillary adenocarcinoma of the prostate. Ito, T., Furusato, M., Akiyama, A., Kato, H., Aizawa, S. Prostate (1995) [Pubmed]
  26. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues. Mizukami, Y., Nonomura, A., Hashimoto, T., Terahata, S., Matsubara, F., Michigishi, T., Noguchi, M. Cancer (1988) [Pubmed]
  27. Papillary thyroid carcinoma without metastases manifesting as an autonomously functioning thyroid nodule. Majima, T., Doi, K., Komatsu, Y., Itoh, H., Fukao, A., Shigemoto, M., Takagi, C., Corners, J., Mizuta, N., Kato, R., Nakao, K. Endocr. J. (2005) [Pubmed]
  28. An episode of silent thyroiditis in a patient with chronic thyroiditis and papillary adenocarcinoma following alpha interferon treatment for hepatitis C. Katabami, S., Kamijo, K., Kodama, T., Fujisawa, Y., Katanuma, A., Yachi, A. Endocr. J. (1993) [Pubmed]
 
WikiGenes - Universities